4//SEC Filing
Martin Steven Robert 4
Accession 0001181431-13-030733
CIK 0001017491other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 4:45 PM ET
Size
6.9 KB
Accession
0001181431-13-030733
Insider Transaction Report
Form 4
Martin Steven Robert
Chief Financial Officer
Transactions
- Purchase
Common Stock
2013-05-23$2.85/sh+20,000$57,000→ 20,000 total - Purchase
Common Stock Warrant
2013-05-23$2.85/sh+20,000$57,000→ 20,000 totalExercise: $3.40From: 2013-05-29Exp: 2018-05-29→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]Purchase in accordance with the Underwriting Agreement, by and between Apricus Biosciences, Inc. and Lazard Capital Markets LLC, dated May 23, 2013.
- [F2]Each warrant is exercisable for 0.50 shares of common stock.
Documents
Issuer
APRICUS BIOSCIENCES, INC.
CIK 0001017491
Entity typeother
Related Parties
1- filerCIK 0001328822
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 4:45 PM ET
- Size
- 6.9 KB